{
  "id": 325,
  "text": "5 \\%$ .Prerequisites such as early FIGO stage (IA2, IB1, IIA primary tumour size $< 4 0 ~ \\mathrm { m m } \\dot { }$ ), no suspicious pre-, and per-operative LNs, and bilateral negative sentinel LNs after ultra staging resulted in remaining false negative result in 0.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 5 \\%$ .Prerequisites such as early FIGO stage (IA2, IB1, IIA primary tumour size $< 4 0 ~ \\mathrm { m m } \\dot { }$ ), no suspicious pre-, and per-operative LNs, and bilateral negative sentinel LNs after ultra staging resulted in remaining false negative result in 0.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在选择宫颈癌患者的治疗方案时，为了降低假阴性结果的出现概率，可以考虑以下术前和术中的因素：\n\n1. **FIGO分期**：选择早期的FIGO分期，如IA2、IB1、IIA，并且原发肿瘤的大小应小于40毫米。早期分期通常显示出更好的预后和更低的假阴性风险。\n\n2. **淋巴结评估**：术前和术中对淋巴结进行评估，并确保没有可疑的淋巴结。对疑似病灶淋巴结进行仔细检查，以减少潜在的假阴性结果。\n\n3. **前哨淋巴结活检**：通过增强的分期方法进行双侧前哨淋巴结的阴性判定。这可以帮助确定淋巴结的病变状况，并降低假阴性概率。\n\n通过结合以上因素，可以在术前和术中更准确地评估宫颈癌患者的病情，从而选择适合的治疗方案，最大限度地提高临床结果的准确性。",
  "query": "在选择宫颈癌患者的治疗方案时，哪些术前和术中的因素可能降低假阴性结果的出现概率？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在选择宫颈癌患者的治疗方案时，哪些术前和术中的因素可能降低假阴性结果的出现概率？\n\n<reference text>: 5 \\%$ .Prerequisites such as early FIGO stage (IA2, IB1, IIA primary tumour size $< 4 0 ~ \\mathrm { m m } \\dot { }$ ), no suspicious pre-, and per-operative LNs, and bilateral negative sentinel LNs after ultra staging resulted in remaining false negative result in 0.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在选择宫颈癌患者的治疗方案时，为了降低假阴性结果的出现概率，可以考虑以下术前和术中的因素：\n\n1. **FIGO分期**：选择早期的FIGO分期，如IA2、IB1、IIA，并且原发肿瘤的大小应小于40毫米。早期分期通常显示出更好的预后和更低的假阴性风险。\n\n2. **淋巴结评估**：术前和术中对淋巴结进行评估，并确保没有可疑的淋巴结。对疑似病灶淋巴结进行仔细检查，以减少潜在的假阴性结果。\n\n3. **前哨淋巴结活检**：通过增强的分期方法进行双侧前哨淋巴结的阴性判定。这可以帮助确定淋巴结的病变状况，并降低假阴性概率。\n\n通过结合以上因素，可以在术前和术中更准确地评估宫颈癌患者的病情，从而选择适合的治疗方案，最大限度地提高临床结果的准确性。"
}